219 related articles for article (PubMed ID: 16515589)
21. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
[TBL] [Abstract][Full Text] [Related]
23. Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.
Kadouri L; Kote-Jarai Z; Easton DF; Hubert A; Hamoudi R; Glaser B; Abeliovich D; Peretz T; Eeles RA
Int J Cancer; 2004 Jan; 108(3):399-403. PubMed ID: 14648706
[TBL] [Abstract][Full Text] [Related]
24. The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.
Sasaki M; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2003 Jun; 305(4):1105-8. PubMed ID: 12767946
[TBL] [Abstract][Full Text] [Related]
25. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
26. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
27. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
29. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.
Given HF; Radbourne R; Oag H; Merritt S; Barclay E; Hanby AM; Lamlum H; McGrath J; Curran C; Tomlinson IP
Eur J Cancer; 2000 Mar; 36(4):533-4. PubMed ID: 10717532
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response.
Lledó B; Llácer J; Turienzo A; Ortiz JA; Guerrero J; Morales R; Ten J; Bernabeu R
Reprod Biomed Online; 2014 Oct; 29(4):509-15. PubMed ID: 25131556
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
[TBL] [Abstract][Full Text] [Related]
33. Heterozygote BRCA1 status and skewed chromosome X inactivation.
Helbling-Leclere A; Lenoir GM; Feunteun J
Fam Cancer; 2007; 6(1):153-7. PubMed ID: 16944269
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
[TBL] [Abstract][Full Text] [Related]
36. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
Li AJ; Karlan BY
Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
[TBL] [Abstract][Full Text] [Related]
37. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure.
Chatterjee S; Singh R; Kadam S; Maitra A; Thangaraj K; Meherji P; Modi D
Hum Reprod; 2009 Dec; 24(12):3230-5. PubMed ID: 19684044
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
Hughes DJ; Ginolhac SM; Coupier I; Barjhoux L; Gaborieau V; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Sobol H; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Yannoukakos D; Mazoyer S; Lynch HT; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
Int J Cancer; 2005 Nov; 117(2):230-3. PubMed ID: 15900600
[TBL] [Abstract][Full Text] [Related]
39. A pharmacogenetic approach to improve low ovarian response: The role of CAG repeats length in the androgen receptor gene.
Lledo B; Llácer J; Ortiz JA; Martinez B; Morales R; Bernabeu R
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():41-45. PubMed ID: 29886316
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.
Yu MW; Yang YC; Yang SY; Chang HC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
Hepatology; 2002 Jul; 36(1):156-63. PubMed ID: 12085360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
